Jeffrey Jacobs

Jeffrey Jacobs

Chief Tech/Sci/R&D Officer at FULCRUM THERAPEUTICS, INC.
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Jeffrey W.
Jacobs
is Chief Scientific Officer at Fulcrum Therapeutics, Inc. since 2022.
Former roles include Senior Director-Development Chemistry at Sunesis Pharmaceuticals, Inc. from 2000 to 2008; Vice President-Medicinal Chemistry at Ardelyx, Inc. from 2008 to 2011; Senior Director-Development Chemistry at Affymax, Inc.; Principal at Vicuron Pharmaceuticals LLC; Principal at The Damon Runyon Cancer Research Foundation; and Chief Scientific Officer at Goldfinch Bio, Inc. Education includes undergraduate studies at Gonzaga University and a doctorate from the University of California, Berkeley.

Jeffrey Jacobs active positions

CompaniesPositionStart
FULCRUM THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-11-30

Former positions of Jeffrey Jacobs

CompaniesPositionEnd
ARDELYX, INC. Chief Tech/Sci/R&D Officer 2021-10-31
VIRACTA THERAPEUTICS, INC. Corporate Officer/Principal 2008-05-31
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jeffrey Jacobs's experience

Training of Jeffrey Jacobs

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

46

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Jeffrey Jacobs